Cargando…
TUMOR RECURRENCE FIVE YEARS AFTER TREATMENT OF CUTANEOUS BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA
For most cutaneous basal cell and squamous cell carcinomas (nonmelanoma skin cancers [NMSC]) data are insufficient to permit evidence-based choices among treatments. To compare tumor recurrence after treatments, we conducted a prospective cohort study of consecutive patients with primary NMSC treate...
Autores principales: | Chren, Mary-Margaret, Linos, Eleni, Torres, Jeanette S., Stuart, Sarah E., Parvataneni, Rupa, Boscardin, W. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711403/ https://www.ncbi.nlm.nih.gov/pubmed/23190903 http://dx.doi.org/10.1038/jid.2012.403 |
Ejemplares similares
-
Development of a patient decision aid for the management of superficial basal cell carcinoma (BCC) in adults with a limited life expectancy
por: Junn, Alexandra, et al.
Publicado: (2020) -
Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
por: Wan, Jun, et al.
Publicado: (2019) -
TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Griewank, Klaus G., et al.
Publicado: (2013) -
Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma
por: Korhonen, Niina, et al.
Publicado: (2020) -
Immunohistochemical expression of CD10 in cutaneous basal and squamous cell carcinomas
por: Shafaei, Shahriar, et al.
Publicado: (2015)